3 top picks in sustainability and software

--  |   12/10/2020 Text size  Decrease  Increase   |  
email_fwd
<p><strong>Lex Hall:</strong> Hi, I'm Lex Hall for Morningstar. Today, I'm joined by Nick Griffin. He's the Chief Investment Officer at Munro Partners where he manages the Global Growth Fund. We're going to talk about a few picks that Nick has his eye on in several fields, one of them being renewable energy, another one in diagnostics and a couple of names in software as well.</p> <p>Hi, again, Nick.</p> <p><strong>Nick Griffin: </strong>Hi, Lex. How are you?</p> <p><strong>Hall:</strong> I'm well. Thanks. Now, let's talk about &ndash; in a previous video, you were talking about opportunities in decarbonization. You've singled out a few &ndash; a couple of Danish names. Tell us about them.</p> <p><strong>Griffin: </strong>Yeah. So, the interesting thing about decarbonization is ultimately you're going to rely on some technology and some IP. As Denmark has been an embracer of obviously clean energy for a very long time and so they happened to build a couple of national champions in Vestas Wind Systems and Vestas Wind Systems is the largest OEM or original equipment manufacturer of wind turbines in the world today. That company has roughly $30 billion market cap. But if you think about the total addressable market or the opportunity over time, there's no reason why Vestas Wind Systems won't be as big as any of the old service companies we've seen come before them, which would put them in potentially a $200 billion market cap at some point in the future. And so, we're really at the start of this journey, and ultimately, that's where they would sit as an OEM.</p> <p>On top of that, you'll need a developer and the number one developer in the world for offshore wind farms happens to be Orsted, also listed in Denmark, roughly $50 billion market cap today, probably a little bit more than that. And they have the know-how to build offshore wind, and that's no difference to being an offshore oil and gas company and the ability to deepwater drilling becomes offshore wind. And ultimately, we see both of those companies effectively replacing their oil and gas equivalents over time. It will take a very long time, but they have their lead today and we think they are well-placed to win.</p> <p><strong>Hall:</strong> OK. Let's switch fields a bit, and let's look at diagnostics. And a company that you've cited there is Thermo Fisher. What do you see in that company in particular?</p> <p><strong>Griffin: </strong>Yeah. So, as a growth investor, we obviously &ndash; we haven't talked much about covid, but covid is here and it's not great. But our goal is to try and find companies that are net beneficiaries of the covid crisis, and there are. I mean, all of us have pivoted our life in some way, shape or form. Thermo Fisher is really sort of a weapons manufacturer in the war, if that makes sense, against covid. They are an enabler of technologies, an enabler of testing. So, Thermo Fisher makes the PCR test that all of us have if we have a covid test. They've actually picked up an extra $5 billion per annum in revenue from covid testing alone, which is more than 20 per cent of their current revenue base. They'll also help build the vaccine. So, every country is going to try and build some vaccine capacity. They'll be in charge of that. They will even be in charge of filling the vaccines in the vials or the tubes, et cetera.</p> <p>And lastly, I think it's fairly obvious that even once covid is passed, and I think covid will pass, countries are going to spend massively to prepare for the next potential pandemic. And so, from that point of view, we do &ndash; we just see them as a great partner of countries all over the world to help them do that. And the market cap of the company is about $150 billion. So, it's a big company but still not a well-known company and hopefully, the market it's going to move into is very, very big.</p> <p><strong>Hall:</strong> Yeah, OK. Yeah, you're right, because a lot of the discussion is being taken up by companies like Gilead Sciences and Pfizer and Astra Zeneca. So, it's interesting&hellip;</p> <p><strong>Griffin: </strong>Yeah, I think the simple thing to say is, we don't really know who's going to come up with a vaccine, and we don't really want to bet on that. We just want to bet on the shovels in this world because we know the war is going to be long and hard and very expensive and that's where Thermo comes in, and you don't have to pay big multiples for it. It's roughly 25 times earnings today.</p> <p><strong>Hall:</strong> OK. And finally, let's turn to software. A couple of names here. We're sort of cheating a bit. We said three topics, but you're getting a little bit more value for your money today. You've singled out Atlassian and ServiceNow. Tell us a bit more about them. Atlassian we know is Australian, but&hellip;</p> <p><strong>Griffin: </strong>Yeah, so the wonder &ndash; if you think about the internet and how it's evolved, it's gone from sort of search to social to streaming videos to now streaming video conferences. And so, the internet is basically enabling software now all over the world and very high-end software to enable collaboration and collaboration has been at the forefront during covid because we've all had to learn how to use these tools. The reason why we flagged these two companies is because they were emerging before this happened and now that emergence will accelerate.</p> <p>And so, if you think about work from home or work from different locations, ServiceNow is sort of the number one IT support software company on the planet and it's very much about cloud-based IT support, so you can operate your business in the cloud. And that's where ServiceNow fits. And we'd see it very much in the slipstream of, say, Salesforce.com.</p> <p>Atlassian is really a collaboration tool that can go across pretty much every industry on the planet. It's very much focused on developers at the moment, but I think that significantly underestimates the other areas it could move into. And so, here, we're just trying to identify those few software companies that are going to become mission critical to people. I think most businesses will end up with five or six software subscriptions, and obviously, Microsoft will be one of them, and maybe Salesforce will be the other and we think these are two potential up and comers that we think will also fit those bills in the long run and that's why we like it.</p> <p><strong>Hall:</strong> OK. So, just to recap, that's Vestas Wind Systems, Orsted and in diagnostics, Thermo Fisher and in software, Atlassian and ServiceNow. Nick Griffin, thanks very much for your insights today.</p> <p><strong>Griffin: </strong>Thanks for having me.</p> <p><strong>Hall:</strong> I'm Lex Hall for Morningstar. Thanks for watching.</p>

Video Archive...

3 top Asian picks on Longlead's radar
22/10/2020  China and Hong Kong have been a happy hunting ground, says Longlead Capital Partners' co-founder Andrew West, who singles out tech, pharmaceuticals and power tools.
3 undervalued travel stocks we like
22/10/2020  These names stand to benefit from a resumption of leisure travel - and are all trading below our fair value estimates.
3 reasons to like bonds
20/10/2020  Morningstar's Mark Preskett looks at three reasons why bonds are an important tool in your investment portfolio.
The monopoly asset that could boost Link
19/10/2020  A bigger stake in the online conveyancer PEXA could be the key to increasing Link Administration's revenue, says Morningstar's Gareth James.
How Longlead Capital defied the covid plunge
16/10/2020  Longlead Capital Partners co-founder Andrew West reveals how his Asia-focused fund managed to make gains during the historic covid-19 sell-off.
Investing basics: why invest in bonds?
16/10/2020  The investment board is back with an explainer on why you might invest in bonds.
Retiring during a pandemic
13/10/2020  How to handle this decision—even when it is made for you.
3 top picks in sustainability and software
12/10/2020  Nick Griffin of Munro Partners reveals why and where he sees opportunities in renewable energy, diagnostics and software. 
Investing basics: what's your personal inflation rate?
09/10/2020  Take stock of your spending to determine if inflation is an issue for you.
Ant Group IPO: What you need to know
09/10/2020  Morningstar analyst Chelsey Tam explains why investors are excited about the flotation of Ant Group and why it's different from Alibaba.
Spotting the winners of tomorrow
06/10/2020  Companies that address the growing demand for decarbonisation will have a 20-year growth opportunity, says Nick Griffin of Munro Partners.
An interview with Whitehaven Coal chief Paul Flynn
30/09/2020  EXCLUSIVE EXTRACT: Morningstar's Mat Hodge and Lex Hall talk to the CEO of the independent producer and exporter about the company's fortunes and its future.
How to get rich slowly
30/09/2020  Slow and steady wins the financial race.
3 top picks in global healthcare
29/09/2020  American Century Investments' low-turnover strategy invests in companies developing vaccines, treatments for neuro-cognitive diseases and innovations in telemedicine.
Investing in the healthcare needs of the future
25/09/2020  By 2050, almost 20 per cent of the global population will be over 65 and demand for healthcare will climb, says Michael Li of American Century Investments.
Morningstar's Mat Hodge on Rio's fortunes
22/09/2020  The destruction of an indigenous cave shelter was unforgiveable but there are other reasons why the iron ore heavyweight is overvalued.
Cannabis: the world in 2030
21/09/2020  Morningstar equity analyst Kristoffer Inton on the outlook for the seven producers under coverage.
3 top picks for the EV revolution
18/09/2020  Morningstar's Seth Goldstein singles out three undervalued stocks that span the entire electric vehicle supply chain.
The 2020 election and your portfolio
18/09/2020  The bumps and bruises of election time may tempt you to shift your portfolio strategy.  
'The tech rally has gone too far'
17/09/2020  UK-based Premier Miton's Simon Evan-Cook says the tech rally of 2020 is reminiscent of the dotcom boom, but inflation could be a bigger threat.
Why EVs will be a common sight on the roads of the future
16/09/2020  By 2025, the cost of batteries and manufacturing will fall and EV functionality will improve, says Morningstar's Seth Goldstein.
Using personal data to better estimate retirement savings
11/09/2020  Estimating the length of your retirement with personalized information will help you save the correct amount.
2 China stocks we like
09/09/2020  Morningstar's Chelsey Tam reveals which stocks and sectors have shone—and which have underwhelmed.
How to be a better investor: episode 3
28/08/2020  Products, services, what is what in the world of finance—and how to look out for yourself
Where to invest for income
24/08/2020  A raft of companies have cut their dividends this year, leaving income investors concerned. But Morningstar's Dan Lefkovitz says there are still plenty of options out there.
DNR Capital's eye for gaming, building supplies and software
18/08/2020  DNR Capital's chief investment officer Jamie Nicol profiles some of the top ten holdings in his Australian Equities High Conviction fund. 
The trouble on Telstra's horizon
17/08/2020  Morningstar's Brian Han explains why he has trimmed his fair value estimate for Australia's dominant telco and the future of its dividend payout.
Finding bargains the market overlooks
14/08/2020  DNR Capital's Jamie Nicol reveals how his Australian Equities High Conviction fund finds quality businesses that will endure difficult conditions.
How to be a better investor: episode 2
13/08/2020  Put your money to work if you're looking for financial freedom.
How to be a better investor: episode 1
10/08/2020  Learn how to picture your goals so you can better reach them.
3 undervalued names in childcare
05/08/2020  Morningstar's Gareth James identifies three sector names trading at attractive discounts in an increasingly 'essential' sector.
Is the 60/40 portfolio dead?
05/08/2020  Reports of the strategy's demise are greatly exaggerated, says Morningstar's Christine Benz.
Why you should ignore a fund's yield
04/08/2020  Investors may assume a fund's yield to determine how much income it will pay, but it's not always so simple, warns Morningstar analyst Rajesh Yadav.
What are the right bonds for retirees today?
03/08/2020  It depends on your expectations and timeframe. Look at bonds as being portfolio stabilisers—sources of cash flow you can draw on when your equities are down, says Christine Benz.
3 top picks in rail, roads and utilities
28/07/2020  When utility stocks plunged during the onset of the pandemic Lazard Asset Management's Warryn Robertson knew it was time to jump in.
Infrastructure stocks in the covid era
24/07/2020  Lazard Asset Management's Warryn Robertson looks at how the pandemic has affected toll roads and airports and what the future of travel holds.
ESG stocks shine in covid-19 crisis
23/07/2020  Morningstar analyst Tancrede Fulop singles out a few companies that have performed well and also led the way in looking after staff. 
Stock-picking: Have you got what it takes?
21/07/2020  New stock-pickers are prone to lose money. Are the lessons worth the price? We ask Morningstar's Christine Benz.
Why mining stocks aren't yield plays
20/07/2020  Elevated iron ore prices have lifted mining company earnings to eye-watering levels but this doesn't make them income stocks, says Morningstar's Mat Hodge.
Commodity stocks riding high, but for how long?
17/07/2020  Local miners should deliver stellar fiscal 2020 results but such outperformance is unlikely to last, says Morningstar’s Mat Hodge.
The rise and rise of Amazon
17/07/2020  --
Should your portfolio shift when the economy slumps?
16/07/2020  How to make some upgrades during this down time.
Will Airbnb IPO or what?
16/07/2020  Covid-19 has made the intended public offering impossible, says Morningstar's Andrew Willis.
3 Japanese stock picks
15/07/2020  JPMorgan's Nicholas Weindling talks opportunities in Japan and reveals the stock that has been his largest holding for almost a decade
Small cap stocks: 'Inevitably, we see it all end in tears'
15/07/2020  The asset class has a habit of outperforming but Morningstar's Ross MacMillan sees signs of a bubble.
A trio of growth stocks
13/07/2020  Rachel Winter of UK fund manager Killik & Co talks payments, social media and investing in her monthly stock pick round-up
3 reasons healthcare is showing fit performance
09/07/2020  And what we expect to see moving forward.
Same old story: growth beats value
07/07/2020  Large growth maintains its supremacy in the Morningstar Style Box during a volatile first half for mutual funds. 
Nikko's 3 top Asian picks
06/07/2020  Nikko Asset Management's Peter Monson looks for strong sustainable returns and he sees that in Asian stocks that span financial exchanges, computer game makers and condiments suppliers.
How appealing are Asian stocks?
02/07/2020  China’s ongoing recovery from COVID-19 presents solid investment opportunities, says Nikko Asset Management.
'Unemployment will be higher, activity lower'
01/07/2020  Aviva Investors' Mark Robertson on the 'second wave', the widening gap between the West and China, portfolio protection and how covid has accelerated the tech revolution.
Smartwatches and luxury watches battle for your wrist
29/06/2020  Does the rise in smartwatches show that data, not diamonds, are a girl's best friend?
3 top picks in water and waste
26/06/2020  They may be 'boring' says Fidelity's Bertrand Lecourt but these names offer solid and long-term returns by delivering essential services.
Tapping opportunities in water and waste
25/06/2020  The growing consumption of water and the increased production of waste make these sectors compelling investments, says Fidelity's Bertrand Lecourt.
Dividends: ‘You have to be very active in stock selection’
23/06/2020  Yield can still be found among global healthcare, technology and consumer staples despite the dismal dividend outlook, says Janus Henderson’s Jane Shoemake.
Airlie went shopping during COVID sell-off
22/06/2020  COVID has given consumers the "fright of their lives" but this fund manager took the opportunity to scoop up bargain bluechips, says portfolio manager Matt Williams.
3 top picks: miner, insurer, fueler
19/06/2020  Mineral Resources, Medibank Private and Ampol are among Airlie Fund Management's preferred stocks, says portfolio manager Matt Williams.
Retail bonanza can’t last, warns Morningstar
16/06/2020  Investors shouldn’t project the pandemic-driven performance of JB HiFi and Harvey Norman too far into the future.
3 Aussie equities to watch
11/06/2020  Lazard Asset Management's Philipp Hofflin explains why mortgage processing, insurance and aluminium production are on his radar.
Are value stocks due for a comeback?
10/06/2020  Value investing has massively underperformed growth over the past decade. Christine Benz talks with Alex Bryan about the fundamental case for value.
3 top picks for a covid crisis
05/06/2020  Specialist consulting firms and chocolate bars. It's a disparate mix but Ned Bell of Bell Asset Management has good reason for seeing value in these sectors right now.
What the share market is missing
04/06/2020  Earnings results will be a rude awakening, says Ned Bell of Bell Asset Management, but there is nevertheless value among some global small- to mid-cap stocks.
The dividend balancing act
03/06/2020  Ensure your dividend-paying companies are more than attractive on the surface with these tips from Morningstar Canada's director of investment research, Ian Tam, CFA.
How dividend-paying stocks fit into retiree portfolios
01/06/2020  Christine Benz suggests retirees should take a balanced approach to these strategies.
Casino comeback and the uncertainty engulfing Seven West
29/05/2020  Most punters would prefer to lose money with their friends in a real casino than gambling online alone in their basement, says Brian Han.
The WFH reality-check for REITs
28/05/2020  Working from home means upheaval for office landlords but shopping mall owners are enjoying the end of hibernation, says Morningstar's Brian Han.
An undervalued, wide-moat name in healthcare
27/05/2020  Companies racing for a coronavirus cure have moved to lofty valuations. Morningstar analyst Alex Morozov is looking for lesser-known healthcare names.
5 investing mistakes to avoid
20/05/2020  Christine Benz discusses pitfalls investors encounter as they navigate volatility and recovery.
Ugly housing outlook won’t last
19/05/2020  Adelaide Brighton, Amcor and Bingo should ride out the housing construction slump with relative ease, says Morningstar’s Grant Slade. 
3 stocks set to clean up
18/05/2020  The biggest corporate hygiene company you never heard of; Dettol's parent company; and a lab supplier are tipped to benefit post-coronavirus.
Greencape's three top picks
13/05/2020  Property listings, software for financial planners and AI machine-learning: Jonathan Koh has scoured the globe for opportunities.
Where to hunt when guidance statements get torn up
12/05/2020  Greencape Capital entered the downturn with a cash reserve that has allowed it to snare some essential services companies at bargain prices, says Jonathan Koh.
Investing basics: the hardest decision in investing
08/05/2020  When and how should you get back into equity markets after panic selling?
Weighing up Australia’s banks
07/05/2020  Bad debts and expected capital raising from three of the big four cloud the outlook for Aussie banks, says Morningstar's Nathan Zaia.
Surprises from Berkshire's annual meeting
05/05/2020  Morningstar's Gregg Warren discusses the meeting's cautious tone, Berkshire's lack of buying during the downturn, and unloading the airlines.
Banks will see out corona crisis
04/05/2020  Loan defaults, shaky house prices and a dividend pause - it's ugly in the short term but Nathan Zaia has long-term faith in Australia's banks.
What the pandemic means for Berkshire Hathaway
30/04/2020  Gregg Warren shares his thoughts on its valuation and more.
Netflix steals the show but for how long?
29/04/2020  What happens when the lockdown ends? The streaming giant may need to get some serious growth in international markets to make up for investor expectations. 
Unique, but normal: riding out this market crisis
27/04/2020  The markets follow patterns. We discuss ways to find your way to the upside of the current environment.
3 defensive utility stocks
23/04/2020  These utility stocks aren't the cheapest but have solid balance sheets and decent yield potential.
What in the world happened to oil prices?
22/04/2020  Amid such a painful downturn and the ensuing demand shock, it's crucial to consider companies that are in sound financial health, says Dave Meats.
'An apocalyptic asset': owning gold
21/04/2020  Gold can be a useful insurance policy for investment portfolios, says Morningstar analyst Kenneth Lamont, but it's not perfect
Energy crisis will be short-lived
20/04/2020  Will energy majors bounce back from the coronavirus-induced turmoil? You bet they will, says Mark Taylor and here are the names to watch.
What role do bonds play in an era of ultralow yields?
16/04/2020  Investors are right to be questioning bonds' role in their portfolios, but they still serve a useful purpose for many.
US tech sector now decently undervalued
14/04/2020  We examine how this sector handled the market turmoil and what to expect
Will energy stocks rise from the ashes?
09/04/2020  Investors' current concerns are justified, but vast long-term opportunities remain in this significantly undervalued sector.
Corona crisis threatens big four dividends
08/04/2020  The short-term may be scary but the major banks' long-term outlook will withstand the shock, says Morningstar's Nathan Zaia.
What to expect as the virus continues
08/04/2020  Christine Benz and Karen Andersen discuss Morningstar's latest views on stopping the spread of the virus as well as the economic implications.
In volatile markets, it's OK to chicken out
03/04/2020  Christine Benz explains why now isn't the time for grand gestures with your investments; instead, take a light touch to them.
Avoiding all eggs in the same basket
02/04/2020  Get the full effect of diversification by considering the correlation of your assets with these tips from Morningstar's Director of Investment Research, Ian Tam
Coronavirus: stock up on quality companies
01/04/2020  Retail and energy companies rank among Morningstar's sector picks, despite seeing some of the sharpest falls since coronavirus hit.
Is this 2008 all over again?
31/03/2020  Eric Jacobson explains why the banking system is not at the centre of the corona crisis, and in fact, is well positioned to be a tool to help solve it.
The critical reason to stay invested
30/03/2020  Why it's important to stay invested to capture critical months for your portfolio, with Morningstar's director of investment research, Ian Tam
How to avoid dividend cuts
27/03/2020  A wave of companies are expected to cut their dividends amid the coronavirus crisis. Morningstar's Dan Lefkovitz explains how to spot a firm that could its pay out.
Healthcare stocks still defensive, says Morningstar
26/03/2020  Respiratory specialist Fisher & Paykel Healthcare is among stocks now enticingly priced as the coronavirus hits markets and the Aussie dollar.
Cheap or nasty? Seven, Nine and Telstra
24/03/2020  A stock that’s heavily sold down isn’t always a screaming buy, as proven by this comparison of debt and other fundamentals among these well-loved companies.
Mining stocks offer price opportunity, dividend threat
20/03/2020  OZ Minerals, South32 and Iluka are among miners dipping into buy territory amid the coronavirus selloff but dividends are at risk, says Morningstar’s Mat Hodge.
Market, economic implications amid latest virus news
20/03/2020  Karen Andersen and Preston Caldwell give us their latest perspectives on healthcare and energy.
'The long-term bounceback will be strong'
17/03/2020  The coronavirus fallout is hurting but there should be a treatment by year end and the rebound will be strong, says Morningstar director of equities Johannes Faul. 
Taking control in time of corona
17/03/2020  In this timely Morningstar panel discussion, but Christine Benz and Andrew Lill provide  concrete tips on how curb your losses and put your money to use.